Cyclopentolate/ketorolac/phenylephrine/tropicamide ophthalmic Interactions
There are 181 drugs known to interact with cyclopentolate/ketorolac/phenylephrine/tropicamide ophthalmic, along with 7 disease interactions. Of the total drug interactions, 8 are major, and 173 are moderate.
- View all 181 medications that may interact with cyclopentolate/ketorolac/phenylephrine/tropicamide ophthalmic
- View cyclopentolate/ketorolac/phenylephrine/tropicamide ophthalmic disease interactions (7)
Most frequently checked interactions
View interaction reports for cyclopentolate / ketorolac / phenylephrine / tropicamide ophthalmic and the medicines listed below.
- Allegra-D 24 Hour (fexofenadine / pseudoephedrine)
- Aspirin Low Strength (aspirin)
- B 100 Complex (multivitamin)
- B-12 (cyanocobalamin)
- BC Headache (aspirin / caffeine)
- Benadryl (diphenhydramine)
- Cipro (ciprofloxacin)
- CoQ10 (ubiquinone)
- Curcumin 95 (turmeric)
- Dulera (formoterol / mometasone)
- Eliquis (apixaban)
- EPA Fish Oil (omega-3 polyunsaturated fatty acids)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Folate Forte (multivitamin)
- Frova (frovatriptan)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Imodium A-D (loperamide)
- Lamictal (lamotrigine)
- Liquid Co-Q10 (ubiquinone)
- Lumigan (bimatoprost ophthalmic)
- Macular Health Formula (multivitamin with minerals)
- Metoprolol Tartrate (metoprolol)
- Mylanta (aluminum hydroxide / magnesium hydroxide / simethicone)
- Nasonex (mometasone nasal)
- Rolaids Regular Strength (calcium carbonate / magnesium hydroxide)
- SAMe (s-adenosylmethionine)
- Selenium TR (selenium)
- Simbrinza (brimonidine / brinzolamide ophthalmic)
- SMZ-TMP DS (sulfamethoxazole / trimethoprim)
- Tylenol (acetaminophen)
Cyclopentolate/ketorolac/phenylephrine/tropicamide ophthalmic disease interactions
There are 7 disease interactions with cyclopentolate / ketorolac / phenylephrine / tropicamide ophthalmic which include:
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.